VCT investor Calculus Capital has made an IRR of 34.3% on the full exit of its investment in AIM-listed British biotechnology business Horizon Discovery.
Fourth core infrastructure secondaries fund is set to be twice the size of its predecessor
IK backed the France-based business in 2014 via its IK VII fund, which closed on €1.7bn in 2013
Move comes as funds invested in DC have exceeded £1bn, but exposure to private markets assets was already available to DB members
GP bought the fasteners and fixings manufacturer as part of a succession process for the company